Population
Cell-free extracts prepared from nuclei isolated from Trypanosoma cruzi
Comparison
Incubation of synthetic RNA transcripts in the… vs Heat or pre-treatment of the extract with…
Design
Preclinical
Authors
Loading...
Supports exploration of T. cruzi RNA processing as a drug target; leaves open clinical translation for Chagas disease.
Demonstrates 3' polyadenylation activity in T. cruzi nuclear extracts requiring an RNA-protein complex, elucidating mRNA processing mechanisms in the Chagas disease agent.
Zwierzynski et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: